BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy18159
(294 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
Length = 269
Score = 141 bits (355), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 73/215 (33%), Positives = 129/215 (60%), Gaps = 10/215 (4%)
Query: 83 SCYAMHIFEYLKSREAEFQIK-DYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNHE 141
S Y I+ YL+ EA ++ YL + T GN MR++L+DW+V+VQ F L E
Sbjct: 4 SEYVKDIYAYLRQLEAAQAVRPKYLLGREVT--GN----MRAILIDWLVQVQMKFRLLQE 57
Query: 142 TLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQD 201
T+Y+ V ++D ++ + LQL+G TA+F++SK+++ PP++ D ++ +TY+
Sbjct: 58 TMYMTVSIIDRFMQNNSVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQ 117
Query: 202 LKDMEIKLVTAIGFDLGIPLSYRFLRRYARCNRIQLPLLTLARYILELSLMEYSLIRESD 261
++ ME+K++ A+ F LG PL FLRR ++ + + TLA+Y++EL++++Y ++
Sbjct: 118 IRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPP 177
Query: 262 SKLACASLYLAQKMNKLTPWNKTLEY---YSEEKL 293
S++A + LA K+ W TL++ Y+EE L
Sbjct: 178 SQIAAGAFSLALKILDNGEWTPTLQHYLSYTEESL 212
>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 260
Score = 140 bits (352), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 73/215 (33%), Positives = 129/215 (60%), Gaps = 10/215 (4%)
Query: 83 SCYAMHIFEYLKSREAEFQIK-DYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNHE 141
S Y I+ YL+ E E ++ YL + T GN MR++L+DW+V+VQ F L E
Sbjct: 2 SEYVKDIYAYLRQLEEEQAVRPKYLLGREVT--GN----MRAILIDWLVQVQMKFRLLQE 55
Query: 142 TLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQD 201
T+Y+ V ++D ++ + LQL+G TA+F++SK+++ PP++ D ++ +TY+
Sbjct: 56 TMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQ 115
Query: 202 LKDMEIKLVTAIGFDLGIPLSYRFLRRYARCNRIQLPLLTLARYILELSLMEYSLIRESD 261
++ ME+K++ A+ F LG PL FLRR ++ + + TLA+Y++EL++++Y ++
Sbjct: 116 IRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPP 175
Query: 262 SKLACASLYLAQKMNKLTPWNKTLEY---YSEEKL 293
S++A + LA K+ W TL++ Y+EE L
Sbjct: 176 SQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESL 210
>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 261
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 69/212 (32%), Positives = 115/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + + +I MR++LVDW+VEV E ++L +
Sbjct: 3 EVPDYQEDIHTYL--REMEVKCKPKVGYMK--RQPDITNSMRAILVDWLVEVGEEYKLQN 58
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TYS +
Sbjct: 59 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYSKK 118
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 119 QVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPANCK-----VESLAMFLGELSLIDA 173
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 174 DPYLKYLPSLIAGAAFHLALYTVTGQSWPESL 205
>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 264
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 4 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 59
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 60 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 119
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 120 QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 174
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 175 DPYLKYLPSVIAAAAFHLALYTVTGQSWPESL 206
>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
Length = 269
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 4 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 59
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 60 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 119
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 120 QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 174
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 175 DPYLKYLPSVIAAAAFHLALYTVTGQSWPESL 206
>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
Length = 268
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 4 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 59
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 60 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 119
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 120 QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 174
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 175 DPYLKYLPSVIAAAAFHLALYTVTGQSWPESL 206
>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
Length = 262
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 4 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 59
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 60 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 119
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 120 QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 174
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 175 DPYLKYLPSVIAAAAFHLALYTVTGQSWPESL 206
>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
Length = 262
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 4 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 59
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 60 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 119
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 120 QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 174
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 175 DPYLKYLPSVIAAAAFHLALYTVTGQSWPESL 206
>pdb|1VIN|A Chain A, Bovine Cyclin A3
Length = 268
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 4 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 59
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 60 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 119
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 120 QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 174
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 175 DPYLKYLPSVIAAAAFHLALYTVTGQSWPESL 206
>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 4 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 59
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 60 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 119
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 120 QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 174
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 175 DPYLKYLPSVIAAAAFHLALYTVTGQSWPESL 206
>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 258
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 109/197 (55%), Gaps = 14/197 (7%)
Query: 96 REAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLG 155
RE E + K + + + +I MR++LVDW+VEV E ++L +ETL+LAV +D +L
Sbjct: 13 REMEVKCKPKVGYMK--RQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLS 70
Query: 156 KVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQDLKDMEIKLVTAIGF 215
+ R LQL+G A+ ++SKF++ PP++++ YI TYS + + ME ++ + F
Sbjct: 71 SMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYSKKQVLRMEHLVLKVLAF 130
Query: 216 DLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY-SLIRESDSKLACAS 268
DL P +FL +Y A C + +LA ++ ELSL++ ++ S +A A+
Sbjct: 131 DLAAPTVNQFLTQYFLHLQPANCK-----VESLAMFLGELSLIDADPYLKYLPSLIAGAA 185
Query: 269 LYLAQKMNKLTPWNKTL 285
+LA W ++L
Sbjct: 186 FHLALYTVTGQSWPESL 202
>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 260
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 68/213 (31%), Positives = 117/213 (54%), Gaps = 16/213 (7%)
Query: 80 LQVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELN 139
++V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L
Sbjct: 1 MEVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQ 56
Query: 140 HETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSI 199
+ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+
Sbjct: 57 NETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTK 116
Query: 200 QDLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLME 253
+ + ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 117 KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCK-----VESLAMFLGELSLID 171
Query: 254 Y-SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 172 ADPYLKYLPSVIAGAAFHLALYTVTGQSWPESL 204
>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 4 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 59
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 60 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 119
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 120 QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 174
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 175 DPYLKYLPSVIAAAAFHLALYTVTGQSWPESL 206
>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 257
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 109/197 (55%), Gaps = 14/197 (7%)
Query: 96 REAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLG 155
RE E + K + + + +I MR++LVDW+VEV E ++L +ETL+LAV +D +L
Sbjct: 13 REMEVKCKPKVGYMK--RQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLS 70
Query: 156 KVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQDLKDMEIKLVTAIGF 215
+ R LQL+G A+ ++SKF++ PP++++ YI TYS + + ME ++ + F
Sbjct: 71 SMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYSKKQVLRMEHLVLKVLAF 130
Query: 216 DLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY-SLIRESDSKLACAS 268
DL P +FL +Y A C + +LA ++ ELSL++ ++ S +A A+
Sbjct: 131 DLAAPTVNQFLTQYFLHLQPANCK-----VESLAMFLGELSLIDADPYLKYLPSLIAGAA 185
Query: 269 LYLAQKMNKLTPWNKTL 285
+LA W ++L
Sbjct: 186 FHLALYTVTGQSWPESL 202
>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 4 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 59
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 60 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 119
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 120 QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 174
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 175 DPYLKYLPSVIAAAAFHLALYTVTGQSWPESL 206
>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 265
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 7 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 62
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 63 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 122
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 123 QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 177
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 178 DPYLKYLPSVIAGAAFHLALYTVTGQSWPESL 209
>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 259
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 1 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 56
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 57 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 116
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 117 QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 171
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 172 DPYLKYLPSVIAGAAFHLALYTVTGQSWPESL 203
>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 260
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 2 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 57
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 58 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 117
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 118 QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 172
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 173 DPYLKYLPSVIAGAAFHLALYTVTGQSWPESL 204
>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 261
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 16/212 (7%)
Query: 81 QVSCYAMHIFEYLKSREAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNH 140
+V Y I YL RE E + K + + ++ +I MR++LVDW+VEV E ++L +
Sbjct: 3 EVPDYHEDIHTYL--REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQN 58
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
ETL+LAV +D +L + R LQL+G A+ ++SKF++ PP++++ YI TY+ +
Sbjct: 59 ETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKK 118
Query: 201 DLKDMEIKLVTAIGFDLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY 254
+ ME ++ + FDL P +FL +Y A C + +LA ++ ELSL++
Sbjct: 119 QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDA 173
Query: 255 -SLIRESDSKLACASLYLAQKMNKLTPWNKTL 285
++ S +A A+ +LA W ++L
Sbjct: 174 DPYLKYLPSVIAGAAFHLALYTVTGQSWPESL 205
>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 258
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 110/197 (55%), Gaps = 14/197 (7%)
Query: 96 REAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLG 155
RE E + K + + ++ +I MR++LVDW+VEV E ++L +ETL+LAV +D +L
Sbjct: 13 REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLS 70
Query: 156 KVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQDLKDMEIKLVTAIGF 215
+ R LQL+G A+ ++SKF++ PP++++ YI TY+ + + ME ++ + F
Sbjct: 71 SMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTF 130
Query: 216 DLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY-SLIRESDSKLACAS 268
DL P +FL +Y A C + +LA ++ ELSL++ ++ S +A A+
Sbjct: 131 DLAAPTVNQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDADPYLKYLPSVIAGAA 185
Query: 269 LYLAQKMNKLTPWNKTL 285
+LA W ++L
Sbjct: 186 FHLALYTVTGQSWPESL 202
>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
Length = 256
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 110/197 (55%), Gaps = 14/197 (7%)
Query: 96 REAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLG 155
RE E + K + + ++ +I MR++LVDW+VEV E ++L +ETL+LAV +D +L
Sbjct: 11 REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLS 68
Query: 156 KVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQDLKDMEIKLVTAIGF 215
+ R LQL+G A+ ++SKF++ PP++++ YI TY+ + + ME ++ + F
Sbjct: 69 SMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTF 128
Query: 216 DLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY-SLIRESDSKLACAS 268
DL P +FL +Y A C + +LA ++ ELSL++ ++ S +A A+
Sbjct: 129 DLAAPTVNQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDADPYLKYLPSVIAGAA 183
Query: 269 LYLAQKMNKLTPWNKTL 285
+LA W ++L
Sbjct: 184 FHLALYTVTGQSWPESL 200
>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
Length = 261
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 110/197 (55%), Gaps = 14/197 (7%)
Query: 96 REAEFQIKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLG 155
RE E + K + + ++ +I MR++LVDW+VEV E ++L +ETL+LAV +D +L
Sbjct: 13 REMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLS 70
Query: 156 KVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQDLKDMEIKLVTAIGF 215
+ R LQL+G A+ ++SKF++ PP++++ YI TY+ + + ME ++ + F
Sbjct: 71 SMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEHLVLKVLTF 130
Query: 216 DLGIPLSYRFLRRY------ARCNRIQLPLLTLARYILELSLMEY-SLIRESDSKLACAS 268
DL P +FL +Y A C + +LA ++ ELSL++ ++ S +A A+
Sbjct: 131 DLAAPTVNQFLTQYFLHQQPANCK-----VESLAMFLGELSLIDADPYLKYLPSVIAGAA 185
Query: 269 LYLAQKMNKLTPWNKTL 285
+LA W ++L
Sbjct: 186 FHLALYTVTGQSWPESL 202
>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
Length = 283
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 66/109 (60%), Gaps = 6/109 (5%)
Query: 117 INAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLG---KVVCSRLNLQLLGATAIF 173
+ +MR++L+DW++EV E ++L+ ET YLA D Y+ VV + LQL+G +++F
Sbjct: 45 LQPKMRAILLDWLMEVCEVYKLHRETFYLAQDFFDRYMATQENVV--KTLLQLIGISSLF 102
Query: 174 VSSKFDDRIPPQLSDLEYICSHTYSIQDLKDMEIKLVTAIGFDLGIPLS 222
+++K ++ PP+L Y+ S ++ ME+ ++ A+ + L PL+
Sbjct: 103 IAAKLEEIYPPKLHQFAYVTDGACSGDEILTMELMIMKALKWRLS-PLT 150
>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
Length = 306
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 35/110 (31%), Positives = 55/110 (50%)
Query: 117 INAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSS 176
I MR +L WM+EV E E LA+ +D YL V + LQLLGA + ++S
Sbjct: 66 IKPHMRKMLAYWMLEVCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQLQLLGAVCMLLAS 125
Query: 177 KFDDRIPPQLSDLEYICSHTYSIQDLKDMEIKLVTAIGFDLGIPLSYRFL 226
K + P + L H S + L+D E+ ++ + +DL +++ FL
Sbjct: 126 KLRETTPLTIEKLCIYTDHAVSPRQLRDWEVLVLGKLKWDLAAVIAHDFL 175
>pdb|1JOW|A Chain A, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|A Chain A, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 254
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 2/122 (1%)
Query: 117 INAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSS 176
+ + R++L+ WM + E+FEL+ L+V ++D YL K ++ LQ +GA + + S
Sbjct: 47 VTVDNRTILLTWMHLLCESFELDKSVFPLSVSILDRYLCKKQGTKKTLQKIGAACVLIGS 106
Query: 177 KFDDRIPPQLSDLEYICSHTYSIQDLKDMEIKLVTAIGFDLGIPLSYRFLRRYARCNRIQ 236
K P +S L Y+ ++ +L + E ++ A+ +D L+ FL CN ++
Sbjct: 107 KIRTVKPMTVSKLTYLSCDCFTNLELINQEKDILEALKWDTEAVLATDFL--IPLCNALK 164
Query: 237 LP 238
+P
Sbjct: 165 IP 166
>pdb|1BU2|A Chain A, X-Ray Structure Of A Viral Cyclin From Herpesvirus Saimiri
Length = 229
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 2/122 (1%)
Query: 117 INAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSS 176
+ + R++L+ WM + E+FEL+ L+V ++D YL K ++ LQ +GA + + S
Sbjct: 26 VTVDNRTILLTWMHLLCESFELDKSVFPLSVSILDRYLCKKQGTKKTLQKIGAACVLIGS 85
Query: 177 KFDDRIPPQLSDLEYICSHTYSIQDLKDMEIKLVTAIGFDLGIPLSYRFLRRYARCNRIQ 236
K P +S L Y+ ++ +L + E ++ A+ +D L+ FL CN ++
Sbjct: 86 KIRTVKPMTVSKLTYLSCDCFTNLELINQEKDILEALKWDTEAVLATDFL--IPLCNALK 143
Query: 237 LP 238
+P
Sbjct: 144 IP 145
>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 257
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 25/63 (39%), Positives = 36/63 (57%)
Query: 121 MRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDD 180
MR ++ WM+EV E + E LA+ +D +L + LQLLGAT +FV+SK +
Sbjct: 42 MRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVASKMKE 101
Query: 181 RIP 183
IP
Sbjct: 102 TIP 104
>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 271
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 25/63 (39%), Positives = 36/63 (57%)
Query: 121 MRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDD 180
MR ++ WM+EV E + E LA+ +D +L + LQLLGAT +FV+SK +
Sbjct: 56 MRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVASKMKE 115
Query: 181 RIP 183
IP
Sbjct: 116 TIP 118
>pdb|1F5Q|B Chain B, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|D Chain D, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
Length = 252
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 45/94 (47%), Gaps = 2/94 (2%)
Query: 116 NINAEMRSVLVDWMVEVQETFELNHETLYLAVKLVD-LYLGKVVCSRLNLQLLGATAIFV 174
+ ++ R VL WM V + ++ LAV L+D L+L + R N Q A A+ +
Sbjct: 43 HFTSQYRKVLTTWMFCVCKDLRQDNNVFPLAVALLDELFLSTRI-DRENYQSTAAVALHI 101
Query: 175 SSKFDDRIPPQLSDLEYICSHTYSIQDLKDMEIK 208
+ K +P + + L Y+C + L +E+K
Sbjct: 102 AGKVRAYMPIKATQLAYLCGGATTADKLLTLEVK 135
>pdb|1G3N|C Chain C, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|G Chain G, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 257
Score = 32.7 bits (73), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 50/100 (50%)
Query: 111 STEKGNINAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLGKVVCSRLNLQLLGAT 170
T + ++ + MR +L WM V + + L + LA+ L+D L S+ + Q G+
Sbjct: 40 GTFQQSLTSHMRKLLGTWMFSVCQEYNLEPNVVALALNLLDRLLLIKQVSKEHFQKTGSA 99
Query: 171 AIFVSSKFDDRIPPQLSDLEYICSHTYSIQDLKDMEIKLV 210
+ V+SK P S L Y + ++S Q+L D E +L+
Sbjct: 100 CLLVASKLRSLTPISTSSLCYAAADSFSRQELIDQEKELL 139
>pdb|1HLG|A Chain A, Crystal Structure Of Human Gastric Lipase
pdb|1HLG|B Chain B, Crystal Structure Of Human Gastric Lipase
Length = 371
Score = 30.0 bits (66), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 141 ETLYLAVKLVDLYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQ 200
+ ++ D +L VCSR L LL + A+F+ FD + S L+ SH +
Sbjct: 201 DKIFYPHNFFDQFLATEVCSREMLNLLCSNALFIICGFDSK-NFNTSRLDVYLSHNPAGT 259
Query: 201 DLKDM-----EIKLVTAIGFDLGIPLSYR 224
+++M +K +D G P+ R
Sbjct: 260 SVQNMFHWTQAVKSGKFQAYDWGSPVQNR 288
>pdb|2I53|A Chain A, Crystal Structure Of Cyclin K
Length = 258
Score = 29.3 bits (64), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 6/79 (7%)
Query: 205 MEIKLVTAIGFDLGIPLSYRFLRRYARC-----NRIQLPLLTLARYILELSLMEYSLIRE 259
+E L+ I FDL + Y+FL +YA+ N+IQ L+ +A + SL ++
Sbjct: 134 LERILLQTIKFDLQVEHPYQFLLKYAKQLKGDKNKIQ-KLVQMAWTFVNDSLCTTLSLQW 192
Query: 260 SDSKLACASLYLAQKMNKL 278
+A A +YLA ++ K
Sbjct: 193 EPEIIAVAVMYLAGRLCKF 211
>pdb|3RTR|A Chain A, A Ring E3-Substrate Complex Poised For Ubiquitin-Like
Protein Transfer: Structural Insights Into Cullin-Ring
Ligases
pdb|3RTR|C Chain C, A Ring E3-Substrate Complex Poised For Ubiquitin-Like
Protein Transfer: Structural Insights Into Cullin-Ring
Ligases
pdb|3RTR|E Chain E, A Ring E3-Substrate Complex Poised For Ubiquitin-Like
Protein Transfer: Structural Insights Into Cullin-Ring
Ligases
pdb|3RTR|G Chain G, A Ring E3-Substrate Complex Poised For Ubiquitin-Like
Protein Transfer: Structural Insights Into Cullin-Ring
Ligases
Length = 368
Score = 27.7 bits (60), Expect = 7.8, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 3/82 (3%)
Query: 102 IKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLGKVVCSR 161
IK YL +++ + NIN M++ + E + + L A + + + KV+ +
Sbjct: 261 IKLYLGYKNKKLRVNINVPMKTEQKQEQETTHKNIEEDRKLLIQAAIVRIMKMRKVLKHQ 320
Query: 162 LNLQLLGATAIFVSSKFDDRIP 183
QLLG +SS+F R+P
Sbjct: 321 ---QLLGEVLTQLSSRFKPRVP 339
>pdb|1LDK|B Chain B, Structure Of The Cul1-Rbx1-Skp1-F Boxskp2 Scf Ubiquitin
Ligase Complex
Length = 366
Score = 27.7 bits (60), Expect = 8.9, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 3/82 (3%)
Query: 102 IKDYLPFQSSTEKGNINAEMRSVLVDWMVEVQETFELNHETLYLAVKLVDLYLGKVVCSR 161
IK YL +++ + NIN M++ + E + + L A + + + KV+ +
Sbjct: 259 IKLYLGYKNKKLRVNINVPMKTEQKQEQETTHKNIEEDRKLLIQAAIVRIMKMRKVLKHQ 318
Query: 162 LNLQLLGATAIFVSSKFDDRIP 183
QLLG +SS+F R+P
Sbjct: 319 ---QLLGEVLTQLSSRFKPRVP 337
>pdb|2HE7|A Chain A, Ferm Domain Of Epb41l3 (Dal-1)
Length = 283
Score = 27.3 bits (59), Expect = 10.0, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 144 YLAVKLVD-LYLGKVVCSRLNLQLLGATAIFVSSKFDDRIPPQLSDLEYICSHTYSIQDL 202
YL ++L D + G++ CS + L LLG+ V S+ D P + +YI ++
Sbjct: 97 YLCLQLRDDIVSGRLPCSFVTLALLGSYT--VQSELGDYDPDECGS-DYISEFRFAPNHT 153
Query: 203 KDMEIKLV 210
K++E K++
Sbjct: 154 KELEDKVI 161
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.317 0.133 0.377
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 7,952,760
Number of Sequences: 62578
Number of extensions: 304488
Number of successful extensions: 782
Number of sequences better than 100.0: 45
Number of HSP's better than 100.0 without gapping: 30
Number of HSP's successfully gapped in prelim test: 15
Number of HSP's that attempted gapping in prelim test: 751
Number of HSP's gapped (non-prelim): 45
length of query: 294
length of database: 14,973,337
effective HSP length: 98
effective length of query: 196
effective length of database: 8,840,693
effective search space: 1732775828
effective search space used: 1732775828
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 51 (24.3 bits)